As early detection and treatment of aggressive PCa leads to better outcomes, prostate-specific antigen (PSA) testing along with digital rectal examination (DRE) became the primary standard screening method in clinical practice to identify men with PCa at an early stage [2]. Here, KLK3 is linked to posterior cortical atrophy.